Johnson & Johnson Breaking Out Diagnostics From Pharmaceuticals Group
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson has decided to create a fourth operating unit by separating the diagnostics business from the Pharmaceuticals Group and placing it under the leadership of Ronald Gelbman, the firm announced June 8.